Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: Correlation with osteoclast-like cell formation

Endocrinology

Volumn 140, Issue 8, 1999, Pages 3552-3561

  Lee, S K ^a   Lorenzo, J A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE;

ANIMAL CELL; ARTICLE; BONE MARROW CULTURE; CALVARIA; CELL COUNT; CELL MATURATION; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION; HORMONAL REGULATION; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

EID: 0033305046     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.8.6887     Document Type: Article

References (40)

1. Cellular and molecular mechanisms in the regulation and function of osteoclasts
2. Advances in bone biology: The osteoclast
3. Modulation of osteoclast differentiation
4. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-jun N-terminal kinase in T cells
5. TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor
6. A homologue of the TNF receptor and its ligand enhance T cell growth and dendritic-cell function
7. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
8. TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts
9. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
10. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
11. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures
12. 2, or parathyroid hormone in the microenvironment of bone
13. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
14. Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
15. Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts
16. Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis
17. Characterization of structural domains of human osteoclastogenesis inhibitory factor
18. Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor
19. Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor
20. Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis
21. Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL
22. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin
23. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification
24. 2 in human bone marrow stroma cells
25. Osteoprotegerin mRNA is increased by interleukin-1α in the human osteosarcoma cell line MG-63 and in human osteoblast-like cells
26. Tumor necrosis factor-α and -β up-regulate the levels of osteoprotegerin mRNA in human osteosarcoma MG-63 cells
27. The TNFR-related protein RANK is the osteoclast differentiation and activation receptor (ODAR) for OPG ligand
28. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures
29. 3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells
30. Preparation and characterization of a mouse osteoclast-like multinucleated cell population
31. Prostaglandins promote osteoclast-like cell formation by a mechanism involving cyclic adenosine 3',5'-monophosphate in mouse bone marrow cell cultures
32. Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures
33. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: A specific marker of the differentiated osteoclast that is regulated by calcitonin
34. Production of both interleukin-1α and β by newborn mouse calvarial cultures
35. Interleukin-6 expression and histomorphometry of bones from mice deficient in receptors for interleukin-1 or tumor necrosis factor
36. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
37. Comparison of the three actin-coding sequences in the mouse; Evolutionary relationships between the actin genes of warm-blooded vertebrates
38. Effects of human recombinant CSF-GM and highly pu-rified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures
39. MCSF release and receptor expression in bone cells
40. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells